Fontugne J, Cai PY, Alnajar H, Bhinder B, Park K, Ye H, Beg S, Sailer V, Siddiqui J, Blattner-Johnson M, Croyle JA, Noorzad Z, Calagua C, MacDonald TY, Axcrona U, Bogaard M, Axcrona K, Scherr DS, Sanda MG, Johannessen B, Chinnaiyan AM, Elemento O, Skotheim RI, Rubin MA, Barbieri CE et al. (2022) Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci JCI Insight, 7 (4) DOI 10.1172/jci.insight.155309, PubMed 35050902 Grasso C, Popovic M, Isaevska E, Lazzarato F, Fiano V, Zugna D, Pluta J, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Bishop DT, Chanock SJ, Chen C, Cortessis VK, Dalgaard MD, Daneshmand S, Ferlin A, Foresta C, Frone MN, Gamulin M, Gietema JA, Greene MH, Grotmol T, Hamilton RJ et al. (2022) Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk Cancer Epidemiol Biomarkers Prev (in press) DOI 10.1158/1055-9965.EPI-22-0123, PubMed 35700037 Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022) Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway J Transl Med, 20 (1), 225 DOI 10.1186/s12967-022-03432-5, PubMed 35568909 More publications